Abstract:
Poly theta inhibitor (I), X is -N-or -C-; ring A is phenyl or a five to ten membered heteroaryl ring containing, inclusive of X, one to four heteroatoms independently selected from nitrogen, oxygen, or sulfur, Ar1 is phenyl, heteroaryl, heterocyclyl, bicyclic heterocyclyl, bridged heterocyclyl, or spiroheterocyclyl, wherein each of the aforementioned ring is substituted with Ra, Rb, and/or Rc,wherein Ra and Rb are independently selected from hydrogen, alkyl, halo, haloalkyl, alkoxy, haloalkoxy, cycloalkyloxy, acyl, acylamino, monoalkylamino, dialkylamino, alkylsulfonyl,cyano, and hydroxy; or Ra and Rb, when on adjacent ring vertices, combine to form a C3-6 cycloalkyl, or Ra and Rb, when on the same ring vertex, combine to form oxo, and Rc is selected from hydrogen, alkyl, halo, haloalkyl, alkoxy, haloalkoxy, hydroxy, hydroxyalkyl, alkoxyalkyl, aminoalkyl, heterocyclylalkyl, heterocyclyloxy, aminocarbonyl; Ar2 is phenyl, heteroaryl, or cycloalkyl, wherein said phenyl and heteroaryl are substituted with Rd, Re and/or Rf, wherein Rd and Re are independently selected from hydrogen, alkyl, halo, haloalkyl, alkoxy, haloalkoxy, hydroxy, and cyano and Rf is selected from hydrogen, alkyl, cycloalkyl, halo, haloalkyl, alkoxy, haloalkoxy, hydroxy, cyano, cyanomethyl, aminocarbonylmethyl, heteroaryl, and heterocyclyl, wherein said heteroaryl and heterocyclyl of Rf are unsubstituted or substituted with one, two, or three substituents independently selected from alkyl, halo, haloalkyl, and hydroxy; R1 is hydrogen, alkyl, halo, haloalkyl, haloalkoxy, alkoxy, hydroxy, cyano, cyanoalkyl,carboxy, alkoxycarbonyl, acylamino, aminocarbonyl optionally substituted heteroaryl, hydroxyalkyl, cycloalkyl, hydroxyalkynyl, alkoxyalkyl, aminoalkyl, aminocarbonylalkyl,sulfonylalkyl, aminosulfonylalkyl, optionally substituted heteroaralkyl, or optionally substituted heterocyclylalkyl; and R2 is hydrogen, alkyl, halo, haloalkyl, haloalkoxy, or cyano; Y is O or S or NH or NRg, Rg is a C1 to C3 aliphatic group; R3 and R4 are H, C1-6 aliphatic group.
Abstract:
L 'invention concerne une composition de caoutchouc pour la fabrication de pneumatiques, à base d'un ou plusieurs élastomères diéniques, d'une ou plusieurs charges renforçantes et d'un système de vulcanisation, caractérisée en ce que ledit système de vulcanisation comprend un ou plusieurs composés thiadiazoles de formule (I).
Abstract:
The present invention is directed to substituted five membered heteroaryl benzamide compounds compounds of formula (I), which are tropomyosin-related kinase (Trk) family protein kinase inhibitors, and hence are useful in the treatment of pain, inflammation, cancer, restenosis, atherosclerosis, psoriasis, thrombosis, a disease, disorder, injury, or malfunction relating to dysmyelination or demyelination or a disease or disorder associated with abnormal activities of nerve growth factor (NGF) receptor TrkA.
Abstract:
Described herein are compounds that are antagonists of PGD 2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD 2 receptors described herein, as well as methods of using such antagonists of PGD 2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD 2 -dependent or PGD 2 -mediated conditions or diseases.
Abstract:
Described herein are compounds that are antagonists of PGD 2 receptors. Also described are pharmaceutical compositions and medicaments that include the antagonists of PGD 2 receptors described herein, as well as methods of using such antagonists of PGD 2 receptors, alone and in combination with other compounds, for treating respiratory, cardiovascular, and other PGD 2 -dependent or PGD 2 -mediated conditions or diseases.
Abstract:
Selective HDAC inhibitors, and pharmaceutical compositions that include the same, are described herein for the treatment of cancer, immunological diseases, inflammatory diseases, and neurological diseases.
Abstract:
The use of N2-phenylamidines of general formula (I) as herbicides is disclosed. In said general formula (I) R2, R3, R4, R5 and R6 are various groups and A is a bond or various single- or multi-atom bridge elements.
Abstract:
Es wird die Verwendung von N2-Phenylamidinen der allgemeinen Formel (I) als Herbizide beschrieben. In dieser allgemeinen Formel (I) stehen R 2, R 3 , R 4 , R 5 und R 6 für verschiedene Reste und A steht für eine Bindung oder für verschiedene 1- oder mehratomige Brückenelemente.
Abstract:
A class of novel acylsulfonamide substituted indole compounds is disclosed together with the use of such compounds for inhibiting sPLA2 mediated release of fatty acids for treatment of inflammatory diseases such as septic shock.
Abstract:
This invention relates to novel spiro containing compounds of Formula (I), and compositions thereof, useful in the treatment of diesease states mediated by the chemokine, Interleukin-8 (IL-8). Compounds of Formula (I) are represented, interalia, by structure (I) wherein, R is -NH -C(X)-NH- (CR13R14)v-Z; Z is optionally substituted phenyl or naphtyl, optionally substituted heteroaryl, optionally substituted C5-8 cycloalkyl, optionally substituted C1-10 alkyl, optionally substituted C2-10 alkenyl, or an optionally substituted C2-10 alkynyl; X is =O, or =S; A is carbon which is contained within a 3-7 membered spiro ring, which ring may optionally contain a heteroatom selected from O/N/S; v is 0, or an integer having a value of 1 to 4; or a pharmaceutically acceptable salt thereof.